A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
Titel:
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
Auteur:
Fung, A.S. Graham, D.M. Chen, E.X. Stockley, T.L. Zhang, T. Le, L.W. Albaba, H. Pisters, K.M. Bradbury, P.A. Trinkaus, M. Chan, M. Arif, S. Zurawska, U. Rothenstein, J. Zawisza, D. Effendi, S. Gill, S. Sawczak, M. Law, J.H. Leighl, N.B.